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Introduction
The brain represents only 2 to 3% of the
body mass, but it receives 15% of the blood
supply and consumes 25% of all glucose at rest
as well as 20% of all oxygen. These observa-
tions emphasize the importance of brain
energy requirements to sustain cerebral activ-
ity. Therefore, it is of crucial importance to
understand how this energy is generated and
which processes require it as well as to deci-
pher the mechanisms that regulate these
processes. In the past 10 yr, important changes
have occurred regarding our understanding of
neuroenergetics (or the different aspects
related to brain energy metabolism). This arti-
cle reviews several of the key aspects that have
emerged during that period.
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Abstract
For years glucose was thought to constitute the sole energy substrate for neurons; it was
believed to be directly provided to neurons via the extracellar space by the cerebral circulation. It
was recently proposed that in addition to glucose, neurons might rely on lactate to sustain their
activity. Therefore, it was demonstrated that lactate is a preferred oxidative substrate for neurons
not only in vitro but also in vivo. Moreover, the presence of specific monocarboxylate transporters
on neurons as well as on astrocytes is consistent with the hypothesis of a transfer of lactate from
astrocytes to neurons. Evidence has been provided for a mechanism whereby astrocytes respond
to glutamatergic activity by enhancing their glycolytic activity, resulting in increased lactate
release. This is accomplished via the uptake of glutamate by glial glutamate transporters, leading
to activation of the Na+/K+ ATPase and a stimulation of astrocytic glycolysis. Several recent
observations obtained both in vitro and in vivo with different approaches have reinforced this
view of brain energetics. Such an understanding might be critically important, not only because it
forms the basis of some classical functional brain imaging techniques but also because several
neurodegenerative diseases exhibit diverse alterations in energy metabolism.
Index Entries: Energy metabolism; glucose; lactate; functional brain imaging; neurodegenera-
tive diseases; neurometabolic coupling.
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Classical Neuroenergetics: 
The Central Dogma
Years of investigation in the field of brain
energy metabolism have led to a large consen-
sus regarding some rules forming what was
believed to be the unquestionable basis of neu-
roenergetics, or how energy is produced and
used to support brain function. Such rules
constitute the so-called “central dogma” of
neuroenergetics and can be stated as follows:
• Energy costs in the central nervous system (CNS)
are dominated by neuronal activity (approx
80–95%), whereas glial cells account for only a
small fraction (approx 5–20%).
• Glucose is the sole energy substrate used to sup-
port function of the adult brain.
• Complete oxidation of glucose provides all the
energy necessary to sustain brain activity.
• Glucose utilization is tightly coupled to synaptic
activity.
Each of these points deserves further elabo-
ration. First, recent calculations and nuclear
magnetic resonance (NMR) measurements
have estimated the relative contribution of
neurons and glia to overall energy expenditure
of the brain as well as the specific cost associ-
ated with different processes involved in brain
function (1,2). Based on this evaluation, only
about 5 to 20% of all energy expenditure
would result from glial cells, whereas the rest
would be directly related to neuronal activity.
This ratio between neuronal and glial energy
costs is in agreement with to the reported dis-
tribution of mitochondria between the two cell
types (98 vs 2% in neurons and astrocytes,
respectively; ref. 3). If it is considered that glu-
cose oxidation is the major source of energy for
the CNS, then it is no surprise that the distrib-
ution of mitochondria corresponds to cellular
energy needs.
A classical statement found in biochemical
textbooks says that the brain relies solely on
blood-borne glucose to provide all the energy
necessary to support brain function. Although
there appears to be no doubt that glucose rep-
resents an essential and major energy substrate
for the brain, there are a few situations for
which other substrates can provide a signifi-
cant amount of energy to fulfill part of the
brain energy requirements. This is especially
the case during brain development. In the first
few hours following delivery, lactate was
found to be an important energy substrate for
the brain, whereas ketone bodies sustain brain
function during the entire preweaning period
(4). Despite these so-called “exceptions,” glu-
cose must still be considered the major, if not
the exclusive, energy substrate for the adult
brain and, by extension, for satisfying neuronal
energy needs.
Parallel measurements of oxygen consump-
tion and glucose utilization have shown a
ratio of approx 5.5, a value close to the pre-
dicted ratio of 6 if glucose was entirely oxi-
dized. Moreover, the cerebral respiratory
quotient that reflects the ratio between CO2
production over O2 consumption was esti-
mated to be 1.0. These global measurements
performed on the resting brain indicate that
carbohydrates, and most likely glucose, are
the major energy substrate for the brain and
that oxidative phosphorylation represents the
major pathway by which adenosine triphos-
phate (ATP) is generated in the brain.
Such observations give relatively little
importance to other substrates and pathways
as sources of energy. However, there exists
much debate surrounding a transient change
in this ratio after specific paradigms of activa-
tion. This situation, called uncoupling, was
first described by Raichle and collaborators (5).
These authors described that an increase in
glucose utilization (and blood flow) in the acti-
vated area of the brain (in this case, the visual
cortex during intense visual stimulation) is not
accompanied by a commensurate (and propor-
tional) increase in oxygen consumption.
Although such a phenomenon can be clearly
observed in specific circumstances, it remains
to be determined whether this is the exception
or the rule.
Concerning the last point of the dogma, it
was assumed that the mechanism subserving
a tight link between glucose utilization and
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synaptic activity was relatively well-under-
stood and could be summarized as follows
(Fig. 1). Increased neuronal activity in any
brain region is accompanied by the formation
and release of vasoactive substances, leading
to a local increase in blood flow. Although the
identity of these substances, their origin, and
their modes of action are varied and their
respective roles are much debated, the end
result is an enhanced blood flow, allowing
more glucose and oxygen to be carried to the
active area. After crossing the blood–brain
barrier (glucose via specific tranporters such
as glucose transporter-1 [55-kDa GLUT1] and
oxygen via simple diffusion), these two sub-
stances penetrate the brain parenchyma and
become directly available to active neurons to
be used and fulfill neuronal energy needs. In
this oversimplified description of the pur-
ported neurometabolic coupling mechanism,
the putative contribution of glial cells has
never been considered.
Astrocytes Exhibit Features 
That Make Them Ideal 
for a Nurturing Role 
Toward Neurons
Some important cellular elements have not
been considered in the classical description of
the coupling mechanism between glucose uti-
lization and neuronal activity (illustrated in
Fig. 1); this is the case of astrocytes. Indeed,
these cells occupy a strategic position, inter-
posed between blood vessels, which represent
the source of glucose, and neurons, which are
the main energy consumers within the brain
parenchyma. Moreover, astrocytes exhibit a
certain number of cytoarchitectural character-
istics that suggest a putative role in the regula-
tion of brain energy metabolism (Fig. 2). They
project toward blood vessel processes that ter-
minate into structures called endfeet, which
almost entirely cover the blood vessel walls.
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Fig. 1. Classical view of how blood flow, glucose utilization, and oxygen consumption are linked to synaptic
activity. Imbalances in ion homeostasis caused by the propagation of action potentials, the release of neurotrans-
mitters, and postsynaptic potentials lead to ATP consumption and create important energy needs in neurons. To
cope with this increased energy demand, vasodilators are produced, the identity of which are still debated.
Because of the formation of vasodilators, an increased blood flow ensues in the activated area, bringing more
glucose and oxygen. Both glucose and oxygen cross the blood–brain barrier (via facilitating transporters and by
simple diffusion, respectively) and reach the extracellular space to be directly taken up by active neurons. Glu-
cose oxidation in neurons provides the necessary ATP to re-establish ion gradients and maintain excitability.
On the membrane of endfeet facing blood ves-
sels, astrocytes express a specific form of glu-
cose transporters: 45-kDa GLUT1 (6,7).
This anatomical arrangement, together with
the expression of glucose transporters, suggests
that astrocytes might represent a privileged
uptake site for glucose as it leaves the circula-
tion to enter the brain parenchyma, as sug-
gested by Golgi more than 100 yr ago (8). On
the other hand, astrocytes also extend processes
that contact neurons and, particularly, enclose
synapses. These processes express receptors
and/or transporters for one or the other neuro-
transmitter (9–12). Such characteristics endow
astrocytes with the capacity to detect synaptic
activity and, possibly, transduce it into a spe-
cific message (13). Recent evidence indicates
that astrocytes can respond to synaptic activity
by releasing themselves, glutamate, or ATP that
in turn would modulate neuronal activity (14).
Accumulating evidence also suggests that
increased synaptic activity could lead to a con-
comitant metabolic response in astrocytes (15).
A series of experiments performed in vitro on
primary cultures of astrocytes characterized a
putative mechanism that might at least partially
account for the observed coupling between
synaptic activity and glucose utilization in vivo.
Glutamate (the major excitatory neurotransmit-
ter in the CNS) was shown to enhance glucose
utilization in cultured astrocytes, as measured
by the uptake of the glucose analog 2-deoxyglu-
cose (16). This effect did not result from the acti-
vation of glutamate receptors, but rather from
the uptake of glutamate via specific Na+-depen-
dent glutamate transporters located on astro-
cytes. Consequently, an increase in the
intracellular Na+ concentration occurred (17),
leading to an activation of the Na+/K+ ATPase
(18). Moreover, it was concluded that a specific
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Fig. 2. Proposed role of astrocytes in coupling synaptic activity to glucose utilization. Astrocytic endfeet cover
the surface of capillaries, and these processes express the glucose transporter GLUT1. In parallel, fine astrocytic
lamellae (which can express receptors and transporters for almost any neurotransmitter) ensheath synapses.
These cytoarchitectual characteristics suggest that astrocytes are ideally located and equipped to couple synap-
tic activity to glucose utilization. To compensate for the use of glucose by astrocytes, these cells release a meta-
bolic intermediate to be used by neurons as an additional energy substrate. The most likely candidate for this
role appears to be lactate, which can be produced in large quantities by astrocytes and can be significantly con-
sumed by neurons.
subunit of the Na+/K+ ATPase (akin to the α2-
subunit) was mobilized in these circumstances
(18). Interestingly, the α2-subunit of the Na+/K+
ATPase was found to be specifically expressed
by astrocytes in vivo and colocalized with both
glial glutamate aspartate transporter (GLAST)
and glutamate transporter-1 (GLT1) on fine
astrocytic processes surrounding glutamatergic
synapses (19).
Based on indirectly measured alterations in
ATP levels on exposure to glutamate in cultured
astrocytes (20), it has been suggested that ATP
consumption by the Na+/K+ ATPase via an
alteration of the ATP/adenosine diphosphate
ratio disinhibits glycolysis and causes an
increase in glucose utilization. In parallel with
this effect on glucose utilization, it was recently
demonstrated that glutamate causes a reversible
enhancement in glucose transport that takes
place within a few seconds after the beginning of
glutamate exposure (21). Therefore, there
appears to be a concerted mechanism to increase
both glucose uptake and utilization in astrocytes
after glutamate exposure. 
The metabolic fate of glucose taken up by
astrocytes upon exposure to glutamate has also
been investigated. A large part of the additional
glucose taken up is converted to lactate and
released by astrocytes (16,22). Although oxida-
tion of pyruvate via the Krebs cycle is a more
efficient pathway regarding ATP production,
the reason that astrocytes favor the formation
of lactate is not completely understood. To sus-
tain a high glycolytic flux (as observed in gluta-
mate-stimulated astrocytes), the cytosolic pool
of nicotinamide adenine dinucleotide (NAD+)
essential at the step catalyzed by the glycer-
aldehyde-3-phosphate dehydrogenase must be
rapidly regenerated. It has been proposed that
the cytosolic pool of NAD+ would be more
rapidly and efficiently maintained by convert-
ing pyruvate to lactate (which requires one
NADH and gives one NAD+) via the reaction
catalyzed by the lactate dehydrogenase (LDH)
present in the cytosol. An additional argument
that has emerged recently is linked to the obser-
vation that astrocytes apparently lack a mito-
chondrial aspartate–glutamate carrier, which is
an essential component of the malate–aspartate
shuttle (23). As a consequence, astrocytes
would have a reduced capacity to shuttle
NADH from the cytosolic to the intramitochon-
drial compartment and to regenerate the
cytosolic NAD+ pool via oxidative metabolism.
Therefore, this would result in their preference
for pyruvate conversion to lactate with regener-
ation of NAD+ within the cytosol.
Some investigators have suggested that the
glycolytic response observed in astrocytes after
exposure to glutamate could be an artifact aris-
ing from culture conditions (24,25). They con-
tended that high glucose (25 mM) concentration
in culture media could favor the emergence of a
glycolytic phenotype in cultured cells and pre-
vents the oxidative use of glutamate to support
its own uptake. A clear demonstration that
enhanced aerobic glycolysis following gluta-
mate exposure is a constitutive property of
astrocytes independent of glucose concentra-
tions was provided recently (26). Therefore, cul-
tured astrocytes prepared from mouse neural
stem cells and cultured from the beginning in
the presence of either 33 or 5 mM displayed the
same glycolytic response to glutamate. When
cultured under the same conditions, undifferen-
tiated stem cells also had a much less glycolytic
phenotype compared to astrocytes, as revealed
by their very low basal lactate production. More-
over, the capacity of astrocytes to enhance aero-
bic glycolysis after glutamate exposure
appeared with their differentiation. The acquisi-
tion of such a metabolic response appears linked
to a particular cell phenotype and is not caused
by cell culture conditions. This conclusion is
strengthened by ex vivo and in vivo observa-
tions demonstrating the existence of a glycolytic
response in astrocytes after brain activation, as
described in the following section.
Ex Vivo and In Vivo Evidence 
for the Involvement of Astrocytes
in Neurometabolic Coupling
Critical evidence for a role of astrocytes in
neurometabolic coupling based on ex vivo
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and in vivo experiments has been provided
recently. Using a specific approach with two
photon confocal microscopy to monitor NADH
fluorescence, Kasischke and coworkers (27)
demonstrated that in hippocampal slices, astro-
cytes in the CA1 area responded to afferent stim-
ulation via Schaffer collaterals with an enhanced
cytosolic NADH signal corresponding to an acti-
vation of glycolysis. This response was not pre-
vented by glutamate receptor antagonists,
leaving the possibility that it could have been
mediated via glutamate uptake. In vivo, it was
shown that injection of antisense oligonu-
cleotides against the glial glutamate transporter
GLAST in the adult rat barrel cortex partly pre-
vents the enhanced deoxyglucose accumulation
observed in the corresponding cortical column
following whisker stimulation (28). Moreover,
using the same whisker-to-barrel model system,
an approx 60% reduction in deoxyglucose accu-
mulation in the appropriate barrel was observed
in 10-d-old knockout mice for either GLAST or
GLT1; this effect persisted in adult GLT1 –/–
mice (29,30). These data suggest that a signifi-
cant proportion of the enhanced glucose utiliza-
tion after activation of a specific brain area
occurs in astrocytes. 
This observation appears to contradict the
central dogma. Indeed, if glucose is the only
significant energy substrate for the brain
(being entirely oxidized to provide all the ATP
necessary to sustain brain function) and if only
5 to 20% of the energy requirements come from
astrocytes, then it should be expected that no
more than 20% of the enhanced glucose utiliza-
tion depend on astrocytes. Such a major depar-
ture from the predicted distribution in glucose
utilization between neurons and glial cells has
been reported in two other cases.
Nehlig and coworkers (31) recently established
a new method combining immunocytochemistry
with high-resolution microautoradiography that
allowed them to quantitate the distribution of
accumulated radioactive deoxyglucose between
astrocytes and neurons in the hippocampus of
resting animals. Their results indicate that about
half of all glucose utilization under these condi-
tions occurs in astrocytes. During activation, this
ratio might even increase in favor of astrocytes,
as suggested by in vitro experiments measuring
glucose uptake after glutamate exposure in both
cell types (21,32) as well as in the aforementioned
experiments in glial glutamate transporter
knockout mice (29,30).
Considering that the same metabolic require-
ments are likely shared between the CNS and
peripheral nervous system (33), ex vivo experi-
ments performed on a stimulated vagus nerve
preparation have provided an interesting insight
regarding this issue. Evaluation of glucose
uptake between axons and Schwann cells upon
stimulation of the axon led to the unexpected
conclusion that 78% of glucose utilization occurs
in Schwann cells, the astrocyte equivalent for the
peripheral nervous system (34). Altogether,
results of these studies are inconsistent with the
previously established rules.
One way to reconcile this paradox is to con-
sider that a fraction of glucose is only partially
metabolized in glial cells and that an intermedi-
ate is released, which is to be used by neighbor-
ing neurons. Evidence points at lactate as the
most likely candidate (34–36). Therefore, con-
sidering the ATP yield of glycolysis for one glu-
cose in astrocytes (2 ATP) and of oxidative
metabolism from two lactates in neurons
(approx 30 ATP), a transfer of lactate between
astrocytes and neurons still allows fulfillment of
the predicted energy needs of the two cell types
and explains the importance of their respective
glucose utilization as measured experimentally.
Recent studies using NMR spectroscopy have
provided a clear demonstration that a net lac-
tate transfer occurs between astrocytes and neu-
rons within the brain and augments with
increasing levels of activity (37,38).
Lactate Represents a Preferential
Oxidative Energy Substrate 
for Neurons
In the past 50 yr, a wide array of studies
using different approaches have led to a simi-
lar conclusion: lactate is efficiently used oxida-
tively by the nervous tissue (for review, see ref.
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39). Therefore, experiments performed on
brain slices (40–42), cultured telencephalic
neurons (43–45), aggregated neuronal cultures
(46), sympathetic ganglia (47–50), and synaptic
terminals (51–53) have consistently reported
that lactate can be oxidized to CO2 by these
preparations—usually more efficiently than
glucose. A direct demonstration that neurons
preferentially use lactate over glucose as an
oxidative substrate was recently provided with
two distinct approaches. By measuring 14CO2
produced by cultured neurons from 14C-
labeled substrates, Sokoloff and colleagues (54)
demonstrated that these cells, in contrast to
astrocytes, have a kinetic preference for oxida-
tion of extracellular lactate over pyruvate pro-
duced intracellularly from glucose. A similar
demonstration was provided using NMR spec-
troscopy. When both substrates were present at
equimolar concentration (5.5 mM), it was cal-
culated that nearly 90% of neuronal oxidative
metabolism was supported by lactate (55). Evi-
dence that lactate represents a significant
energy substrate for the adult brain have also
been provided. Thus, NMR spectroscopy
showed that intravenously injected lactate was
readily metabolized by the brain in a compart-
ment lacking pyruvate carboxylase activity
(56,57). Because pyruvate carboxylase activity
is found only in astrocytes, it was suggested
that lactate utilization occurs predominantly in
neurons. Additionally, it was concluded from
the labeling pattern of compounds such as glu-
tamine, glutamate, and γ-aminobutyric acid
(GABA) that lactate must be used in large part
by glutamatergic neurons (58). An in vivo con-
firmation of the preferred use of lactate over
glucose was recently obtained in human sub-
jects. Amiel and coworkers (59) showed that
raising plasma lactate levels to values reached
during a moderate exercise substantially
reduced brain glucose utilization, as revealed
by the use of labeled fluorodeoxyglucose com-
bined with positron emission tomography. 
Although several studies have indicated that
lactate could be an important energy substrate
for neurons under resting conditions, few have
examined changes in substrate utilization on
stimulation. Two interesting observations were
made recently. First, using fluorescent analogs
of deoxyglucose and confocal microscopy, it
was demonstrated that glutamate exposure
induces opposite effects in astrocytes and neu-
rons within the same culture preparation:
although glutamate increased glucose trans-
port in astrocytes, it reduced it in neurons (32).
Indeed, the ratio of glucose transport between
astrocytes and neurons varied from 1.27:1 at
rest to 15.8:1 after addition of glutamate. This
change in neurons occurs within a few seconds,
depends on the activation of AMPA receptors,
and is fully reversible upon glutamate removal. 
Therefore, it appears that glutamate favors
glucose uptake in astrocytes and restricts its
entry into neurons. These conditions highly
contribute to promotion of lactate production
by astrocytes and its oxidative use by neurons.
The latter point is supported by the observa-
tion that addition of lactate to the medium con-
comitantly with glutamate further reduces
glucose uptake in neurons (32).
Another set of experiments performed in
hippocampal slices provided an interesting
insight regarding this issue. Kasischke and
colleagues (27) observed a rapid activation of
oxidative metabolism in dendrites of CA1
neurons upon Schaffer collateral activation,
which was followed by enhanced glycolysis
in neighboring astrocytes. If we consider the
aforementioned results regarding opposite
glucose uptake changes after glutamate expo-
sure, then the most probable sequence of
events occurring on activation involving glu-
tamatergic synapses is an oxidative use of
pre-existing extracellular lactate by neurons
that are then supplied upon prolonged stimu-
lation by lactate produced by astrocytes. Mea-
surements performed in vivo have already
provided observations consistent with this
view.
Magnetic resonance spectroscopy in humans
has revealed an initial “dip” in lactate concen-
tration on activation in the corresponding
brain region that could correspond to its oxida-
tive use by neurons (60). Moreover, rapid and
synchronized decreases in extracellular lactate
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levels monitored with lactate-sensitive micro-
electrodes have been observed after electrical
stimulation of the hippocampus in the rat (61).
Although early or initial measurements
revealed a transient decrease in lactate levels,
observations made later usually found an
increase in lactate or lactate “peaks” (62–64).
This biphasic response is entirely consistent
with a rapid oxidative burst in neurons sus-
tained by extracellular lactate and later sup-
plied via lactate production by astrocytes that
replenish the extracellular pool.
Cellular Distribution of LDH
Isoforms and Monocarboxylate
Transporters Supports the Concept
of an Astrocyte–Neuron 
Lactate Shuttle
It has been proposed that neurons behave as
lactate “sinks” whereas astrocytes would act as
lactate “source” within the brain parenchyma.
The necessity of a direct transfer of lactate
from astrocytes to neurons is alleviated by the
existence of an extracellular lactate pool, as the
extracellular lactate concentration was found
to be approx 1 mM in both rats and humans
(65). After activation in a specific brain region,
a net lactate transfer occurs as a result of early
oxidative consumption in neurons and late
production by astrocytes. This overall process
forms what has been named the
astrocyte–neuron lactate shuttle hypothesis
(for review, see ref. 66). However, for this
mechanism to operate, some key elements in
the metabolism and transport of lactate are
either required or must at least be indicative
that the mechanism can occur. This is the case
for the distribution of LDH isoforms.
LDH is a tetrameric enzyme formed from
two types of subunits in the CNS: the muscle
type (or M), and the heart type (or H). Isoforms
enriched in H subunits (e.g., LDH1 formed of
four H subunits) are found highly expressed in
tissues or cell types that consume lactate (e.g.,
heart), whereas isoforms with high M subunit
content (e.g., LDH5 with four M subunits) are
abundant in lactate-producing tissues or cells
(e.g., fast-twitch muscle). It was discovered
that neurons in the brain predominantly
express the LDH1 isoform, whereas the LDH5
isoform is more abundant in astrocytes (67,68).
Lactate is an hydrophilic substance and can
not easily cross plasma membranes at physi-
ological pH; instead, it requires specific
transporters. A family of monocarboxylate
transporters was recently described (for
review, see ref. 69). Among the 14 members
identified on the basis of sequence homolo-
gies, only the first 4 monocarboxylate trans-
porters (MCT1–MCT4) were capable of
transporting monocarboxylates that include
lactate, pyruvate, and ketone bodies. MCT1, -2,
and -4 have been observed in the CNS (70).
MCT1 and MCT4 are abundantly expressed
by astrocytes in various brain regions (70–76).
In contrast, MCT2 is the major neuronal MCT
(73–78). Considering that MCT2 exhibits a
much higher affinity than MCT1 and, espe-
cially, MCT4, the reported distribution is con-
sistent with export of lactate by astrocytes and
neuronal lactate uptake. At the subcellular
level, MCT2 was observed not only on den-
drites and axons of neurons in various areas
(78) but also localized in the postsynaptic den-
sity area of glutamatergic synapses but not
GABAergic synapses (77,79). Additionally,
MCT2 was observed to colocalize with the
GluR2/3 subunits of AMPA receptors in the
postsynaptic density area and also within the
postsynaptic spine head, forming an intracel-
lular pool (79).
It was suggested that MCT2, together with
AMPA receptors, could undergo a process of
exo-/endocytosis at the plasma membrane of
the postsynaptic density area, providing a
mean to adjust energy substrate delivery with
the level of postsynaptic activity (79). As a
proof of principle, MCT2 expression in cul-
tured neurons was enhanced through a viral
vector-based approach (80). After exposure to
glutamate, it was demonstrated that lactate
oxidation was enhanced in neurons overex-
pressing MCT2, compared to untransfected
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cultures. Additionally, the possibility that the
expression levels of MCTs could be controlled
was recently demonstrated. It was shown that
noradrenaline causes a transient increase in the
expression of MCT2 in cultured neurons, an
effect occurring at the translational, rather than
at the transcriptional, level (81). This observa-
tion suggests that in addition to a rapid control
of MCT2 expression at the plasma membrane,
there may also be some long-term mechanisms
to adapt lactate delivery to active neurons as a
function of the global level of activity in a spe-
cific brain area.
Astrocytes As the Origin of Specific
Brain Imaging Signals and As 
a Putative Therapeutic Target 
in Neurodegenerative Diseases
The demonstration that astrocytes represent
a major site of glucose uptake (becoming par-
ticularly prominent following activation) has
important implications for the interpretation of
signals arising from functional brain imaging
techniques. The first direct consequence is that
for imaging performed with fluoro-
deoxyglucose combined with positron emis-
sion tomography, the signal obtained largely
originates from astrocytes. Although generally
it reflects neuronal activity because the mecha-
nism in astrocytes is related to synaptic activity,
there could be some situations where this rela-
tionship is altered (82–86).
A second important point concerns the
impact of inhibitory vs excitatory activity on
both energetics and brain imaging signals,
which is an issue under much debate (87,88).
In cultured astrocytes, research showed that
GABA (the major inhibitory neurotransmitter in
the CNS) does not cause any change in glucose
utilization, as opposed to the prominent effect of
glutamate (20). These results were interpreted
as an indication that inhibitory neurotransmis-
sion might not induce a similar imaging signal
based on energetics, a view consistent with
some observations made in vivo (89).
A new dimension was recently added to the
contribution of astrocytes in brain imaging sig-
nals. It was observed that the metabolic
response of astrocytes to glutamate (i.e.,
enhanced glucose utilization) propagates from
one cell to another through a regenerative
mechanism of glutamate release and re-uptake
(90). This observation has important implica-
tions for the interpretation of brain imaging
signals that might spread over larger areas
than where they originate.
In a certain number of neurodegenerative
diseases, deficits in brain energy metabolism
were evidenced and often revealed by func-
tional brain imaging. This is the case of
Alzheimer’s disease, for which deficits even
preceded the appearance of the first symp-
toms, suggesting that it could be a contributing
factor to, rather than a consequence of, cell
loss. In parallel, indications that lactate can be
neuroprotective in different conditions have
started to emerge.
Therefore, lactate was shown to at least
partly reverse the deleterious effect of glucose
or oxygen deprivation (91–95), ischemia (96),
or excitotoxicity (97,98). Such observations
gave rise to the concept that boosting neuroen-
ergetics by enhancing lactate production by
astrocytes, enhancing lactate consumption by
neurons, or both might be beneficial and pro-
vide neuroprotection (99). This principle was
directly tested experimentally, and it was dis-
covered that transfecting a glucose transporter
in astrocytes (that enhanced lactate produc-
tion) or a MCT in neurons (that favored lactate
consumed) was neuroprotective against an
excitotoxic insult (80). Moreover, a combina-
tion of the two treatments was even more
effective than each approach separately.
Further support for the idea that bolstering
energy metabolism in astrocytes might represent
a valuable therapeutic strategy was recently pro-
vided. It was shown that the ampakine CX546,
belonging to a well-known family of cognitive
enhancers and neuroprotective agents (100),
enhances the metabolic response of astrocytes to
glutamate (101). This effect, which might con-
tribute to the neuroprotective effects of this class
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of compounds, points at the possibility of specif-
ically targeting astrocytes and their energy
metabolism as a prime therapeutic target—par-
ticularly for neurodegenerative diseases such as
Alzheimer’s disease.
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